- Home
- SNTI vs NIPG Comparison
SNTI vs NIPG Comparison
Compare SNTI & NIPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNTI
- NIPG
- Stock Information
- Founded
- SNTI 2016
- NIPG 2014
- Country
- SNTI United States
- NIPG Sweden
- Employees
- SNTI N/A
- NIPG N/A
- Industry
- SNTI Biotechnology: Pharmaceutical Preparations
- NIPG
- Sector
- SNTI Health Care
- NIPG
- Exchange
- SNTI Nasdaq
- NIPG NYSE
- Market Cap
- SNTI 85.3M
- NIPG 94.5M
- IPO Year
- SNTI N/A
- NIPG 2024
- Fundamental
- Price
- SNTI $3.10
- NIPG $1.47
- Analyst Decision
- SNTI Strong Buy
- NIPG Strong Buy
- Analyst Count
- SNTI 1
- NIPG 1
- Target Price
- SNTI $12.00
- NIPG $12.00
- AVG Volume (30 Days)
- SNTI 225.5K
- NIPG 64.1K
- Earning Date
- SNTI 05-06-2025
- NIPG 04-30-2025
- Dividend Yield
- SNTI N/A
- NIPG N/A
- EPS Growth
- SNTI N/A
- NIPG N/A
- EPS
- SNTI N/A
- NIPG N/A
- Revenue
- SNTI N/A
- NIPG $85,266,306.00
- Revenue This Year
- SNTI N/A
- NIPG $20.82
- Revenue Next Year
- SNTI N/A
- NIPG $29.70
- P/E Ratio
- SNTI N/A
- NIPG N/A
- Revenue Growth
- SNTI N/A
- NIPG 1.91
- 52 Week Low
- SNTI $1.52
- NIPG $0.99
- 52 Week High
- SNTI $16.94
- NIPG $17.76
- Technical
- Relative Strength Index (RSI)
- SNTI 41.06
- NIPG N/A
- Support Level
- SNTI $3.10
- NIPG N/A
- Resistance Level
- SNTI $3.61
- NIPG N/A
- Average True Range (ATR)
- SNTI 0.40
- NIPG 0.00
- MACD
- SNTI -0.07
- NIPG 0.00
- Stochastic Oscillator
- SNTI 9.50
- NIPG 0.00
About SNTI Senti Biosciences Inc.
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.
About NIPG NIP GROUP INC SPON ADS EACH REPR 2 CL A ORD SHS
NIP Group Inc is a digital entertainment company built for the growing gaming and esports industry. NIP Group integrates multiple businesses such as talent agency, event production, game-themed hotels and game publishing to create transformative entertainment experiences that inspire, connect fans, expand global influence, and achieve deep interaction on platforms where digital native players gather. It currently has operation centers in Sweden, China, Abu Dhabi, and Brazil, and its esports teams cover multiple game projects and are active in the top event stages.